{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:18:24Z","timestamp":1792671504904,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.vaccine.2006.09.029","type":"journal-article","created":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T11:29:52Z","timestamp":1158838192000},"page":"2518-2527","source":"Crossref","is-referenced-by-count":96,"title":["Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children"],"prefix":"10.1016","volume":"25","author":[{"given":"Isabelle","family":"Henckaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Durant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"De Grave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2006.09.029_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/MMBR.59.4.591-603.1995","article-title":"Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines","volume":"59","author":"AlonsoDeVelasco","year":"1995","journal-title":"Microbiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.029_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2006.09.029_bib3","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.33.10.2759-2762.1995","article-title":"Six newly recognized types of Streptococcus pneumoniae","volume":"33","author":"Henrichsen","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.029_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2006.09.029_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","article-title":"Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine","volume":"20","author":"Black","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2006.09.029_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.029_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1183\/09031936.01.00084401","article-title":"Pneumococcal vaccination: current and future issues","volume":"18","author":"\u00d6rtqvist","year":"2001","journal-title":"Eur Respir J"},{"issue":"2 Pt 1","key":"10.1016\/j.vaccine.2006.09.029_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis","volume":"106","author":"American Academy of Pediatrics. Committee on Infectious Diseases","year":"2000","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.029_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.137.4.1181","article-title":"Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant","volume":"137","author":"Anderson","year":"1986","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.09.029_bib10","first-page":"144","article-title":"Progress toward elimination of Haemophilus influenzae type b disease among infants and children\u2014United States, 1987\u20131993","volume":"43","author":"Centers for Disease Control and Prevention (CDC)","year":"1994","journal-title":"Morb Mortal Wkly Rep"},{"issue":"9381","key":"10.1016\/j.vaccine.2006.09.029_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.vaccine.2006.09.029_bib12","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"9465","key":"10.1016\/j.vaccine.2006.09.029_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"9546","key":"10.1016\/j.vaccine.2006.09.029_bib14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case\u2013control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.09.029_bib15","unstructured":"Whitney C. Effect of pneumococcal conjugate vaccine in invasive disease in the U.S. International Symposium on Pneumonia and Pneumococcal Diseases (ISPPD4), Helsinki, Finland, May 9\u201313, 2004."},{"issue":"16","key":"10.1016\/j.vaccine.2006.09.029_bib16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.vaccine.2006.09.029_bib17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.09.029_bib18","unstructured":"World Health Organization. Pneumococcal conjugate vaccines. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series 2005; 927 (Annex 2):64\u201398."},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.029_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/314845","article-title":"Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2006.09.029_bib20","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/IAI.58.12.3871-3876.1990","article-title":"Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4","volume":"58","author":"Musher","year":"1990","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.029_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1086\/515259","article-title":"Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats","volume":"177","author":"Stack","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.029_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/CDLI.7.3.468-476.2000","article-title":"Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?","volume":"7","author":"Soininen","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.029_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.029_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"19","key":"10.1016\/j.vaccine.2006.09.029_bib25","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJM199505113321907","article-title":"Pathogenesis of pneumococcal infection","volume":"332","author":"Tuomanen","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.029_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF02113425","article-title":"Pneumococcal virulence factors and host immune responses to them","volume":"14","author":"Watson","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.029_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CDLI.8.2.363-369.2001","article-title":"Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?","volume":"8","author":"V\u00e4kev\u00e4inen","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.029_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.029_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/CDLI.10.6.1019-1024.2003","article-title":"Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae","volume":"10","author":"Romero-Steiner","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.029_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/CDLI.12.2.287-295.2005","article-title":"Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae","volume":"12","author":"Hu","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.029_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CDLI.12.1.19-27.2005","article-title":"Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies","volume":"12","author":"Fleck","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.09.029_bib32","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/IAI.67.7.3690-3692.1999","article-title":"Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains","volume":"67","author":"Weiser","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.09.029_bib33","unstructured":"ICH. Guideline for industry. Q2A, Text on validation of analytical procedures, www.fda.gov\/cder\/Guidance\/ichq2a.pdf; March 1995."},{"key":"10.1016\/j.vaccine.2006.09.029_bib34","unstructured":"ICH. Guidance for industry. Q2B, Validation of analytical procedures: methodology, http:\/\/www.fda.gov\/Cder\/guidance\/1320fnl.pdf; November 1996."},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.029_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"23","key":"10.1016\/j.vaccine.2006.09.029_bib36","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.029_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.09.029_bib38","series-title":"International Symposium on Pneumonia and Pneumococcal Diseases (ISPPD3), Anchorage, Alaska, May 5\u20138","article-title":"Conjugation chemistry effects immunological reactivity and epitope expression of the pneumococcal 19F polysaccharide","author":"Concepcion","year":"2002"},{"key":"10.1016\/j.vaccine.2006.09.029_bib39","unstructured":"Siber GR. Basis for developing a pneumococcal conjugate vaccine for adults. VRBPAC meeting; 17 November 2005, http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/slides\/5-4188S2_3.ppt."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06010310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T15:50:31Z","timestamp":1707234631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06010310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0264410X06010310"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}